| |
|
|
|
Kumpel BM. Would it be possible to prevent HPA-1a alloimmunization to reduce the incidence of fetal and neonatal alloimmune thrombocytopenia? Transfusion. 2012;52:1393-1397. Thèmes : Hémostase ; maj-2012-11

|
|
|
|
|
Kumpel BM. Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn. Clin Exp Immunol. 2008;154:1-5. Thèmes : Allo-immunisation - MHNN ; maj-2009-01
|
|
|
|
|
|
|
|
|
|
|
|
|
Kumpel BM, Beliard R, Brossard Y, Edelman L, de Haas M, Jackson DJ, Kooyman P, Ligthart PC, Monchatre E, Overbeeke MAM, Puillandre P, de Romeuf C, Wilkes AM. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report. Transfus Clin Biol. 2002;9:45-53. Thèmes : Systèmes de groupes sanguins ; Méthodes en immuno-hématologie
|
|
|
|
|
Kumpel BM. Labeling D+ RBCs for flow cytometric quantification of fetomaternal hemorrhage after the RBCs have been coated with anti-D. Transfusion. 2001;41:1059-1063. Thèmes : Allo-immunisation - MHNN
|
|
|
|
|
|
|
|
|
|